Sotorasib versus Docetaxel for treatment of US and Chinese patients with advanced non-small-cell lung cancer with KRAS p.G12C-mutated: A cost-effectiveness analysis to inform drug pricing.

Details

Language :

English

ISSN :

00257974

Volume :

102

Issue :

50

Database :

Complementary Index

Journal :

Medicine

Publication Type :

Academic Journal

Accession number :

175570987

Full Text :

https://doi.org/10.1097/MD.0000000000036387